“Patient with Refractory Mixed Phenotype Acute Leukemia Achieves Complete Remission with Human CD19-Targeted CAR-T Cell Therapy”

https://pubmed.ncbi.nlm.nih.gov/38115347

A patient with refractory mixed phenotype acute leukemia achieved complete remission after treatment with human CD19-targeted CAR-T cell therapy, highlighting the potential of this approach for managing this challenging disease.